Latest main publications
Together, let’s overcome cancer !
Oncology
Lung fibrosis
Preclinical Imaging Methodology
Access all of our publications :
Conferences & Presentations
Oral presentations
2025
- C Petitot : Theranostic Anti-CD38 Antibody for Combined Positron Emission Tomography and Lutetium-177 Radionuclide Therapy in Lymphoma, EANM (European Association of Nuclear Medicine), 04-08 oct 2025 – Barcelona, Spain.
- PS Bellaye : In vivo SPECT imaging of Fibroblast Activation Protein as a non-invasive biomarker of anti-fibrotic efficacy of Gp96 inhibition in idiopathic pulmonary fibrosis, EMIM (European Molecular Imaging Meeting), 11-14 Mars 2025 – Bilbao, Spain.
2024
- PS Bellaye : In vivo SPECT imaging of Fibroblast Activation Protein as a non-invasive biomarker of anti-fibrotic efficacy of Gp96 inhibition in idiopathic pulmonary fibrosis, EANM (European Association of Nuclear Medicine), 19-23 oct 2024 – Hamburg, Germany.
- C Petitot : Imagerie TEP théranostique préclinique des cancers CD38 positifs avec les sondes [Zr89]Zr-DFO/DOTAGA-Isatuximab et [Zr89]ZrDFO/DOTAGA-Daratumumab, Oncotrans, 5-6 Nov 2024, Dijon, France.
- PS Bellaye : Radiothérapie interne vectorisée contre les cellules T régulatrices exprimant GARP après amorçage de la tumeur par radiothérapie externe dans un modèle syngénique murin de cancer du sein triple négatif, Oncotrans, 5-6 Nov 2024, Dijon, France.
2023
- A Courteau : Is multiple-mouse PET/MR imaging possible in preclinical oncology?, EANM (European Association of Nuclear Medicine), 09-13 oct 2024 – Vienna, Austria.
- A Dias : Inhibition de Gp96 comme stratégie anti-fibrotique dans la fibrose pulmonaire idiopathique et son suivi par l’imagerie SPECT in vivo de la Fibroblast Activation Protein, J2R (Journées de recherche respiratoire), 13-14 Oct 2023, Tours, France.
- PS Bellaye : Hypoxie et fibrose pulmonaire – Comment détecter et quantifier l’hypoxie du poumon fibrosant ?, Activités scientifiques conjointes RSRQ-RESPIRenT-BeRS (France/Belgique/Canada), visioconférence, 3 février 2023.
2021
- A Bouchard : 99mTc-Tilmanocept SPECT imaging as a potential non-invasive method to quantify CD206+ tumor- associated M2-like macrophages, Forum du Cancéropôle, 17-18 Nov 2021, Dijon, France.
Poster presentations
2025
- J Frenay, F Mialhe, PS Bellaye, C Andres, A Baeza Garcia, B Collin, AMM Dias, Monitoring CAR therapies via multimodal imaging (SPECT and PET) based on Na+/I- symporter (NIS), EMIM (European Molecular Imaging Meeting), 11-14 Mars 2025 – Bilbao, Spain.
- A Kownacka, PS Bellaye, M Moreau, C Petitot, S Jedidi, M Claron, M Guillemin, J Simonet, M Monterrat, A Helbling, A Oudot, R Douhard, A Cochet, A Courteau, S Ladoire, B Collin, AMM Dias, Imagerie préclinique SPECT des cancers HER2 positifs avec [111In]In-DOTAGA-trastuzumab et [111In]In-DOTAGA-pertuzumab, EMIM (European Molecular Imaging Meeting), 11-14 Mars 2025 – Bilbao, Spain.
- A Courteau, M Roche, C Petitot, A Oudot, C Gervasoni,J Paris, R Decréau, PS Bellaye, B Collin, AMM Dias, SPIOs development for theranostic purposes in glioblastoma, EMIM (European Molecular Imaging Meeting), 11-14 Mars 2025 – Bilbao, Spain.
2024
- Pommerolle L, Beltramo G, Biziorek L, Truchi M, Dias AMM, Dondaine L, Tanguy J, Pernet N, Goncalves V, Bouchard A, Monterrat M, Savary G, Pottier N, Ask K, Kolb MRJ, Mari B, Garrido C, Collin B, Bonniaud P, Burgy O*, Goirand F*, Bellaye PS* – CD206+ macrophages are relevant non-invasive imaging biomarkers and therapeutic targets in experimental lung fibrosis. ICLAF (International Colloquium on Lung and Airway Fibrosis), Athènes, 12-16 oct 2024.
- J Frenay*, P-S. Bellaye*, F. Mialhe, C. Andres, A. Baeza Garcia, B. Collin, A.M.M. Dias – Monitoring CAR therapies via multimodal imaging (SPECT and PET) based on Na+/I– symporter (NIS). Journées scientifiques du GDR-AIM. 28-30 oct 2024.
- A. Dias, M. Privat, L. Proukhnitzky, C. Racoeur, M. Guillemin, E. Chazeau, H. Jardel, N. Le-Guern, V. Goncalves, M. Moreau, B. Collin, F. Denat, P.-S. Bellaye, C. Paul, C. Goze, T. Gautier, Development of a monomolecular multifunctional imaging probe for dual labeling of LDL to image and characterize atherosclerotic plaques, EASC (European Atherosclerosis Society Congress), 2024, Lyon, France.
- A Kownacka, PS Bellaye, M Moreau, C Petitot, S Jedidi, M Claron, M Guillemin, J Simonet, M Monterrat, A Helbling, A Oudot, R Douhard, A Cochet, A Courteau, S Ladoire, B Collin, AMM Dias, Imagerie préclinique SPECT des cancers HER2 positifs avec [111In]In-DOTAGA-trastuzumab et [111In]In-DOTAGA-pertuzumab, Oncotrans, 5-6 Nov 2024, Dijon, France.
- J. Frenay, P-S. Bellaye, M. Moreau, M. Claron, L. Ringenbach, C. Ferrand, F. Denat, A. MM. Dias, B. Collin, Cancers hématologiques surexprimant IL-1RAP : utilisation d’un anticorps radiomarqué pour une approche théranostique, Oncotrans, 5-6 Nov 2024, Dijon, France.
2023
- Dias A, Petitot C, Frenay J, Oudot A, Helbling A, Moreau M, Monterrat M, Guillemin M, Ranjit N, Courteau A, Cochet A, Collin B, Bellaye PS – Preclinical Theranostic PET imaging in CD30 positive cancers with [Zr89]Zr-DFO-Brentuximab vedotin. WMIC (Word molecular imaging society), Prague, 5-9 Sept 2023.
- Dias A, Sikner H, Garnier A-G, Tanguy J, Bouchard A, Moreau M, Claron M, Burgy O, Goirand F. Bonniaud P, Collin B, Bellaye P-S – Inhibition de Gp96 comme stratégie anti-fibrotique dans la fibrose pulmonaire idiopathique et son suivi par l’imagerie SPECT in vivo de la Fibroblast Activation Protein. Journées de Recherche Respiratoire (J2R), 13-14 oct 2023.
- Vizier R, Sikner H, Garnier AR, Moreau M, Claron M, Denat F, Bellaye PS*, GoncalvesV* – Preclinical evaluation of Lysyl Oxidase-like 2 as a target for the nuclear imaging of idiopathic pulmonary fibrosis. European Molecular Imaging Meeting (EMIM), Salzbourg, 14-17 Mars 2023.
- A Oudot, P Provent , A Courteau, N Hoffmann, M Guillemin, J Longin, S Belderbos, B Collin, M Hillairet de Boisferon, A Cochet , C Berthet. Simultaneous 18F-FDG PET-MR imaging for metastases identification in a disseminated human preclinical melanoma model, EMIM (European Molecular Imaging Meeting), 14-17 Mars 2023 – Salzburg, Austria.
- AMM Dias, C Petitot, J Frenay, A Oudot, A Helbling, M Moreau, M Monterrat, M Guillemin, N Ranjit, A Courteau, A Cochet, B Collin, PS Bellaye, Preclinical Theranostic PET imaging in CD30 positive cancers with [Zr89]Zr-DFO-Brentuximab vedotin, WMIC (World Molecular Imaging Society), 5-9 Sept 2023.
- A Courteau, M Roche, C Petitot, A Oudot, C Gervasoni,J Paris, R Decréau, PS Bellaye, B Collin, AMM Dias, SPIOs development for theranostic purposes in glioblastoma, WMIC (World Molecular Imaging Society), 5-9 Sept 2023.
- A Courteau, M Roche, C Petitot, A Oudot, C Gervasoni, PS Bellaye, J Paris, B Collin, AMM Dias, Development and in vitro analysis of SPIONs for theranostic purposes in cancer, C’Nano (the nanoscience meeting), 15-17 Mar 2023, Poitiers, France.
2022
- J Tanguy, PM Boutanquoi, O Burgy, L Dondaine, B Uyanik, C Garrido, P Bonniaud, PS Bellaye*, F Goirand* – Nci-41356, a promising small chemical inhibitor of HSPB5 in idiopathic pulmonary fibrosis? ICLAF (International Colloquium on Lung and Airway Fibrosis), Reykjavik, 1-5 oct 2022
- Sikner H, Bouchard A, Garnier AR, Tanguy J, Moreau M, Claron M, Bonniaud P, Collin B, Bellaye PS – Inhibition of Gp96 as anti-fibrotic strategy in Idiopathic pulmonary fibrosis and its monitoring by Fibroblast Activation Protein in vivo imaging. ICLAF (International Colloquium on Lung and Airway Fibrosis), Reykjavik, 1-5 oct 2022.
- Sikner H, Bouchard A, Garnier AR, Tanguy J, Moreau M, Claron M, Bonniaud P, Collin B, Bellaye PS – Inhibition of Gp96 as anti-fibrotic strategy in Idiopathic pulmonary fibrosis and its monitoring by Fibroblast Activation Protein in vivo imaging. Journées de Recherche Respiratoire (J2R), Reims, 14-15 oct 2022.
- Garnier A-R., Tanguy J., Sikner H., Bouchard A., Moreau M., Claron M., Bonniaud P., Collin B., Bellaye P-S – HSP90 comme biomarqueur et cible thérapeutique dans la Fibrose Pulmonaire Idiopathique. Journées de Recherche Respiratoire (J2R), Reims, 14-15 oct 2022.
- Vizier R; Garnier A ; Sikner H ; Moreau M.; Goirand F ; Bonniaud P. ; Collin B. ; Goncalves V.* ; Bellaye PS* – Lysyl oxidase-like 2 (LOXL2) comme cible d’imagerie pour la quantification et le suivi de la progression de la fibrose pulmonaire expérimentale. Journées de Recherche Respiratoire (J2R), Reims, 14-15 oct 2022.
- Bouchard A, Sikner H, Moreau M, Dias A, Kohli E, Collin B, Bellaye PS – Glycoprotein-A repetition predominant, a target of interest for SPECT imaging of triple negative breast cancer. Champalimaud Research Symposium 2022 (CRSy22). Lisbonne, 19-21 oct 2022.
2021
- Bouchard A, Sikner H, Moreau M, Limagne E, Bellaye PS*, Kohli E*, Collin B* – 99mTc-Tilmanocept SPECT imaging as a potential non-invasive method to quantify CD206+ tumor- associated M2-like macrophages. European Molecular Imaging Meeting (EMIM). Göttingen, 24-27 août 2021.
- J. Frenay*, PS. Bellaye*, M. Moreau, C. Rossi, O. Casasnovas, L. Ringenbach, C. Ferrand, B. Collin – Theranostic approach of CD38 and IL-1RAP positive haematological malignancies based on radiolabelled antibodies. EANM (European Association of Nuclear Medicine). 20-23 oct 2021 (virtuel).
Our partners
